A Comparative Study Between Intravenous Magnesium Sulphate and Intravenous Isoxsuprine for Arrest of Preterm Labour

Rohit Jeswani; Yamini Patil; Sangeeta Lalwani; Monika Dudve

doi:10.55489/njmr.14012024988

Authors

Rohit Jeswani Amaltas Institute of Medical Science, Madhya Pradesh, India
Yamini Patil Amaltas Institute of Medical Science, Madhya Pradesh, India
Sangeeta Lalwani Amaltas Institute of Medical Science, Madhya Pradesh, India
Monika Dudve Amaltas Institute of Medical Science, Madhya Pradesh, India

DOI:

https://doi.org/10.55489/njmr.14012024988

Keywords:

Magnesium Sulphate, Isoxsuprine, preterm labour, tocolysis, Effacement, cervical dilatation

Abstract

Introduction: Wide use of medical management of preterm labour has been obstructed due to low success rate of arrest of labour. This is aggravated by higher incidence of serious side effect of the available tocolytic agents, especially beta-mimetic tocolytics. With this background, the present study was carried out to compare the efficacy and maternal side effect of magnesium sulphate and Isoxsuprine in the arrest of preterm labour

Methodology: This was a comparative prospective interventional study conducted among pregnant women coming to department of obstetrics and gynaecology with 28 to 37 weeks of gestation. Patients were divided in to two groups - Group 1 receiving Isoxsuprine and Group 2 receiving Magnesium Sulphate. Base line profile and outcome were compared between the two study groups.

Results: Magnesium sulphate was more effective in arresting labour compared to Isoxsuprine (p<0.05). Tachycardia and hypotension were observed more frequently in group1 (Isoxsuprine) compared to group 2 (MgSO₄). In cases having <1 cm dilatation and or less than 25% effacement MgSO4 was significantly more effective that Isoxsuprine for tocolysis.

Conclusion: Magnesium sulphate is a more effective tocolytic agent than Isoxsuprine. Magnesium sulphate produce lesser maternal and foetal side effects like hypotension, palpitation, tachycardia as compared to Isoxsuprine.

References

American Congress of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 31: assessment of risk factors for pre-term birth. Obstet Gynecol. 2001;98(4):709-716. Doi: https://doi.org/10.1097/00006250-200110000-00035

Sukladas S, Prasad US. A prospective study to assess the neonatal mortality and morbidity associated with preterm la-bor and delivery in a tertiary care hospital. Ann Int Med Den Res. 2016;2(2):116-9.

Egbe TO, Nana Njamen T, Halle Ekane G, Tsingaing JK, Tch-ente CN, Beyiha G, et al. Outcome of late second trimester emergency cerclage in patients with advanced cervical dilata-tion with bulging amniotic membranes: a report of six cases managed at the douala general hospital, Cameroon. ISRN Ob-stet Gynecol. 2013; 2013:843158. Doi: https://doi.org/10.1155/2013/843158 PMid:24371527 PMCid:PMC3859266

Chatterjee J, Gullam J, Vatish M. The management of preterm labor. Arch Dis Child Fetal Neonatal Ed. 2007;92:F88-F93. Doi: https://doi.org/10.1136/adc.2005.082289 PMid:17337673 PMCid:PMC2675479

Chandraharan E, Arulkumaran S. Recent advances in man-agement of preterm labor. J Obstet Gynecol India. 2005;55(2):118-24.

Hass DM, Benjamin T, Sawyer R, Quinney SK. Short-term tocolytics for preterm delivery: current perspectives. Int J Women's Health. 2014;6:343-9. Doi: https://doi.org/10.2147/IJWH.S44048 PMid:24707187 PMCid:PMC3971910

Schleußner E. The prevention, diagnosis and treatment of premature labor. Dtsch Arztebl Int. 2013;110(13):227-36. Doi: https://doi.org/10.3238/arztebl.2013.0227 PMid:23596503 PMCid:PMC3627164

Pradyuman V, Mekhla G. A comparative study of two tocolytic agents for inhibition of preterm labor. Gujarat MedJ. 2014; 69(1): 28-31.

McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity. The New England journal of medicine. 1985;312(2):82-90. Doi: https://doi.org/10.1056/NEJM198501103120204 PMid:3880598

Fuchs F (1976). Prevention of prematurity. American Journal of Obstetrics and Gynaecology 126 809. Doi: https://doi.org/10.1016/0002-9378(76)90670-0 PMid:11689

How Hy, Hughes SA and Vogll RL et al., (1995). Oral terbutal-ine in outpatient management of preterm labour. American Journal of Obstetrics and Gynaecology 173 1518. Doi: https://doi.org/10.1016/0002-9378(95)90642-8 PMid:7503194

Mahajan A, Marwah P. Arrest Of Preterm Labour: A Compara-tive Study Between Magnesium Sulphate And Isoxsuprine. Intl J Basic Applied Med Sci 2014;4(3):19-25.

Jagapriya JS, Latha KL, Jayashree V. A Comparative Study On Magnesium Sulphate And Isoxsuprine In The Management Of Preterm Labour. Int. J. Modn. Res. Revs.2016; 4(11: 1383- 1387

Mahajan A, Marwah P. Isoxsuprine as a tocolytic agent in pre-term labor. Int J Basic Appl Med Sci. 2015;5(3):86-91

Giorgino FL, Egan CG. Use of Isoxsuprine hydrochloride as a tocolytic agent in the treatment of preterm labor: a systematic review of previous literature. Arzne Im It Telforschung. 2010;60(7):415-420. Doi: https://doi.org/10.1055/s-0031-1296305 PMid:20712130

National Formulary of India (2011). Available at http://www.cdsco.nic.in/writereaddata/NFI_2011%20(1).pdf. Accessed on September 22, 2017.

Rodriguez MI. The role of magnesium sulfate in preterm la-bor: a best evidence review. Medscape. Dec 04, 2009.

Sudarshan, S.2002. Role of magnesium sulphate in suppres-sion of preterm labour. Journal of Obstetrics and Gynaecolo-gy of India 52(2) 53-57

Jaju PB, Sood A, Chavan V, Devgarha G, Jain S, Kundapur V et al. Practice patterns in the management of preterm labor in India: a multi-centric, retrospective study. Int J Reprod Con-tracept Obstet Gynecol 2017;6:5306-12. Doi: https://doi.org/10.18203/2320-1770.ijrcog20175233

Peter S Bernstein, Mary King. Using nifedipine as a tocolytic in preterm labor. Medscape. Aug 18, 2004.

Srividya Nemani, Mary Manjula Dasari, Vamsi Mudadla, Sudharani Balla. Role of magnesium sulphate in preterm la-bour. IAIM, 2018; 5(2): 168-173.